APA (7th ed.) Citation

AI, A., J, G., C, C., RH, K., P, M., BY, K., . . . J, K. (2026). Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 44(10), 883. https://doi.org/10.1200/JCO-25-01648

Chicago Style (17th ed.) Citation

AI, Apostol, et al. "Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 44, no. 10 (2026): 883. https://doi.org/10.1200/JCO-25-01648.

MLA (9th ed.) Citation

AI, Apostol, et al. "Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 44, no. 10, 2026, p. 883, https://doi.org/10.1200/JCO-25-01648.

Warning: These citations may not always be 100% accurate.